Source:
https://scmp.com/country-reports/country-reports/topics/australia-business-report-may-2019/article/3011240/lacorium
Country Reports

LaCorium Health’s products manage various skin conditions

  • The company’s Dermal Therapy brand features the latest advancements in technology and application
Steven Sher, managing director

Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com

A parent will do anything to ease the discomfort of a child suffering from skin irritations. What started as a father’s desperate effort to manage his son’s eczema led Steven Sher, LaCorium Health Australia’s managing director, to realise the lack of safe and effective skin care products in the market.

Sher persisted to develop innovative and highly potent creams, ointments and lotions for various skin conditions. Since being founded in 1990, LaCorium Health has created a portfolio of high-quality and highly effective health care solutions that are backed by clinical data and distributed in more than 40 countries worldwide.

Representing years of in-depth research and collaboration with leading medical professionals, the Australian company’s Dermal Therapy brand showcases the latest advancements in skin care technology and application. Dermal Therapy’s range of foot, lip and skin care products feature balanced blends of the highest quality ingredients that address dry and sensitive skin problems.

We support our product claims with clinical studies and medical research, and we stick to the philosophy of efficacy so we make promises that we deliver Steven Sher, managing director

“We support our product claims with clinical studies and medical research, and we stick to the philosophy of efficacy so we make promises that we deliver,” Sher says. “As a result, we exceed customer expectations and get repeat purchases.” Consumers and pharmacists across Australia, Singapore, Malaysia, Hong Kong and mainland China who have sampled LaCorium Health’s superior formulations testify to the products’ effectiveness. The same potency and safety philosophy applies to the company’s newly launched Little Bodies brand – a regimen of steroid-free eczema care designed for babies and kids.

LaCorium Health will launch 14 new products this year. Experienced in providing regulatory assistance globally, it seeks to work with mid-sized distribution companies with sales and marketing capabilities in Japan, South Korea, Indonesia, Thailand and Taiwan.

“We plan to have a bigger portfolio of products in the midterm to help more consumers with their skin conditions,” Sher says. “We seek true partnerships and long-term arrangements to grow our business.”